Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians.

Palsson OS, Whitehead WE, van Tilburg MA, Chang L, Chey W, Crowell MD, Keefer L, Lembo AJ, Parkman HP, Rao SS, Sperber A, Spiegel B, Tack J, Vanner S, Walker LS, Whorwell P, Yang Y.

Gastroenterology. 2016 Feb 13. pii: S0016-5085(16)00180-3. doi: 10.1053/j.gastro.2016.02.014. [Epub ahead of print]

PMID:
27144634
2.

Bowel Disorders.

Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R.

Gastroenterology. 2016 Feb 18. pii: S0016-5085(16)00222-5. doi: 10.1053/j.gastro.2016.02.031. [Epub ahead of print]

PMID:
27144627
3.

Eluxadoline for Irritable Bowel Syndrome with Diarrhea.

Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L, Covington PS.

N Engl J Med. 2016 Jan 21;374(3):242-53. doi: 10.1056/NEJMoa1505180.

PMID:
26789872
4.

Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome.

Nee J, Zakari M, Lembo AJ.

Expert Opin Pharmacother. 2015;16(18):2781-92. doi: 10.1517/14656566.2015.1101449. Epub 2015 Nov 11. Review.

PMID:
26558923
5.

New and Emerging Treatment Options for Irritable Bowel Syndrome.

Lacy BE, Chey WD, Lembo AJ.

Gastroenterol Hepatol (N Y). 2015 Apr;11(4 Suppl 2):1-19.

6.

Novel Therapies in IBS-D Treatment.

Nee J, Zakari M, Lembo AJ.

Curr Treat Options Gastroenterol. 2015 Dec;13(4):432-40. doi: 10.1007/s11938-015-0068-5.

PMID:
26432092
7.

Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial.

Dossett ML, Mu L, Davis RB, Bell IR, Lembo AJ, Kaptchuk TJ, Yeh GY.

PLoS One. 2015 Sep 30;10(9):e0136855. doi: 10.1371/journal.pone.0136855. eCollection 2015.

8.

Letter: seasonality in eosinophilic oesophagitis and food bolus obstruction - what about recurrent episodes? - Authors' reply.

Sengupta N, Tapper EB, Lembo AJ.

Aliment Pharmacol Ther. 2015 Oct;42(7):937. doi: 10.1111/apt.13348. No abstract available.

PMID:
26331557
9.

The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review.

Moayyedi P, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Ford AC.

Clin Transl Gastroenterol. 2015 Aug 20;6:e107. doi: 10.1038/ctg.2015.21.

10.

Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.

Lacy BE, Schey R, Shiff SJ, Lavins BJ, Fox SM, Jia XD, Blakesley RE, Hao X, Cronin JA, Currie MG, Kurtz CB, Johnston JM, Lembo AJ.

PLoS One. 2015 Jul 29;10(7):e0134349. doi: 10.1371/journal.pone.0134349. eCollection 2015.

11.

Response to Pasalar et al.

Dossett ML, Davis RB, Lembo AJ, Yeh GY.

Am J Gastroenterol. 2015 Jun;110(6):936. doi: 10.1038/ajg.2015.111. No abstract available.

PMID:
26052775
12.

The clinical predictors of aetiology and complications among 173 patients presenting to the Emergency Department with oesophageal food bolus impaction from 2004-2014.

Sengupta N, Tapper EB, Corban C, Sommers T, Leffler DA, Lembo AJ.

Aliment Pharmacol Ther. 2015 Jul;42(1):91-8. doi: 10.1111/apt.13237. Epub 2015 May 12.

PMID:
25963885
13.

Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients.

Hall KT, Tolkin BR, Chinn GM, Kirsch I, Kelley JM, Lembo AJ, Kaptchuk TJ, Kokkotou E, Davis RB, Conboy LA.

Brain Behav. 2015 Jan;5(1):39-44. doi: 10.1002/brb3.294. Epub 2014 Nov 13.

14.

Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C.

Camilleri M, Lembo AJ, Lavins BJ, MacDougall JE, Carson RT, Williams VS, Nelson LM, Shiff SJ, Currie MG, Kurtz CB, Johnston JM.

United European Gastroenterol J. 2015 Feb;3(1):53-62. doi: 10.1177/2050640614555946.

15.

The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials.

Chang L, Lembo AJ, Lavins BJ, Shiff SJ, Hao X, Chickering JG, Jia XD, Currie MG, Kurtz CB, Johnston JM.

Aliment Pharmacol Ther. 2014 Dec;40(11-12):1302-12. doi: 10.1111/apt.12985. Epub 2014 Oct 13.

16.

Introduction: opioid-induced constipation.

Lembo AJ.

Am J Gastroenterol Suppl. 2014 Sep 10;2(1):2. doi: 10.1038/ajgsup.2014.2. No abstract available.

PMID:
25207606
17.

American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.

Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Quigley EM; Task Force on the Management of Functional Bowel Disorders.

Am J Gastroenterol. 2014 Aug;109 Suppl 1:S2-26; quiz S27. doi: 10.1038/ajg.2014.187. Review. No abstract available.

PMID:
25091148
18.

The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis.

Moayyedi P, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Ford AC.

Am J Gastroenterol. 2014 Sep;109(9):1367-74. doi: 10.1038/ajg.2014.195. Epub 2014 Jul 29. Review.

PMID:
25070054
19.

Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.

Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P.

Am J Gastroenterol. 2014 Oct;109(10):1547-61; quiz 1546, 1562. doi: 10.1038/ajg.2014.202. Epub 2014 Jul 29. Review.

PMID:
25070051
20.

Complementary and alternative medicine use by US adults with gastrointestinal conditions: Results from the 2012 National Health Interview Survey.

Dossett ML, Davis RB, Lembo AJ, Yeh GY.

Am J Gastroenterol. 2014 Nov;109(11):1705-11. doi: 10.1038/ajg.2014.108. Epub 2014 Jul 8.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk